A new type of Aptamer Drug Conjugate (ApDC) developed by a group of Chinese researchers has recently been granted orphan drug designation from the U.S. Food and Drug Administration (FDA), bringing new ...
Veronika Skvortsova noted that research is currently ongoing on drugs targeting glioblastomas and melanomas - malignant brain tumors and skin cancers ...